The Development of a Deep Learning Model to Classify Inflammation from ⁹⁹ᵐTc-Maraciclatide Scans Presented at the BNMS Autumn Meeting 2023

London, UK, 31 October 2023. Serac Healthcare Limited (“Serac Healthcare” or “the Company”), a clinical radiopharmaceutical company developing innovative molecular imaging technologies, announces that a poster titled “Automatic Classification of Inflamed Joint Regions in Rheumatoid Arthritis using Deep Networks with ⁹⁹ᵐTc-Maraciclatide Imaging” is being presented at the British Nuclear Medicine Society meeting taking place on 31 October in London.

Share this article with a friend

Create an account to access this functionality.
Discover the advantages